|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers 显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 2 | Pharmacokinetic and pharmacodynamic interaction between tolvaptan, a non-peptide A VP antagonist, and furosemide or hydrochlorothiazide 显示文摘 | SHOAF S BRAMER S BRICMONT P | 2007 | J Cardiovasc Pharmacol2007，50，2： | 1 |
| 3 | Phar-macokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 4 | Body mass index predicts new-onset atrial fibrillation after cardiac surgery显示文摘 | Bramer S van Straten AH Soliman Hamad MA | 2011 | Eur J Cardiothorac Surg2011，40，5： | 1 |
| 5 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 6 | Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease显示文摘 | Bramer SL Forbes WP Mallikaarjun S | 1999 | Clinical Pharmacokinet1999，37，2： | 1 |
| 7 | Pharmacokinetic and pharma- codynamic interaction between tolvaptan,a non-peptide AVP antagonist, and furosemide orhydrochlomthiazide显示文摘 | Shoal S E Bramer S L Bricmont P | 2007 | J Cardiovasc Pharmacol2007，50，2： | 1 |
| 8 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | S Mallikaarjun D E Salazar S L Bramer | | 0，，： | 1 |
| 9 | Effects of choline on health across the life course: a systematic review 显示文摘 | Leermakers E T Moreira E M Kiefte-de Jong J C Darweesh S K Visser T Voortman T Bautista P K Chowdhury R Gorman D Bramer W M Felix J F Franco O H | 2015 | Nutrition Reviews2015，73，8： | 1 |
| 10 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR DE BRAMER S | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 11 | Pharmacokinetics, tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 12 | Met- hod for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MS显示文摘 | BRAMER S L TATA P N VENGURLEKAR S S | 2001 | J Pharmaceutical Biomed Anal2001，26，4： | 1 |
| 13 | Pharmacokinetics,tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 14 | Does new-onset posto- perative atrial fibrillation after coronary artery bypass grafting affect postoperative quality of life显示文摘 | Bramer S Ter Woorst FJ Geldorp MW | 2013 | J Thorac Cardiovasc Surg2013，146，1： | 1 |
| 15 | Pharmacokinetics, tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar D E Bramer S L | 2004 | J clin Pharmacol2004，44，2： | 1 |
| 16 | Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，： | 1 |
| 17 | Theimpact of new-onset postoperative atrial fibrillation on mortalityafter coronary artery bypass grafting显示文摘 | Bramer S van Straten AH Soliman Hamad MA etal | 2010 | Ann Thorac Surg2010，90，2： | 1 |
| 18 | Pharrnaeokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in Normal Healthy Volunteers显示文摘 | Mallikaarjun S Salazar D E Bramer S L | | J Clin Pharmaeol0，44，： | 1 |
| 19 | Pharmacoki netics, tolerability, and safety of aripiprazole fol lowing multiple oral dosing in normal healthy volun teers显示文摘 | Mallikaarjun S Salazar DE Bramer SL | 2004 | J Clin Pharmacol2004，44，2： | 1 |
| 20 | Pharmacokinetics,tolerability,and safety of aripiprazole following multiple oral dosing in normal healthy volunteers显示文摘 | MALLIKAARJUN S SALAZAR D E BRAMER S L | 2004 | J Clin Pharmacol2004，44，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员